Category Archives: Alternative Medicine

A new alternative for pain treatment has opened in Coon Rapids.

Just down the road from Mercy Hospital, Minnesota Integrative Medicine and Acupuncture is the newest acupuncture and eastern medicine clinic in the city. The clinic opened the first week of February.

My goal is to help people who dont really have another resort, owner Kierstin Beaman said.

She has spent a decade studying chronic conditions to help people suffering long-term pain. Many of her patients have taken more conventional routes, but to no avail.

It really dives down deep and treats the chronic issues at hand and kind of gives long-term effects so theyre able to get back to a pain-free life, Beaman said.

Beaman is a locally and nationally licensed, board certified acupuncturists and herbalist. She earned her masters at Northwestern Health Sciences University. Before that she earned an undergraduate degree in biological research, Beaman said.

Beamans interest in acupuncture comes partially from seeing her mother, Kim Olson, suffer from chronic pain conditions and partially from her husbands fight with cancer.

My mother has been struggling with chronic issues my whole entire life, and western medicine has really fallen short her whole life, Beaman said.So the only kind of pain relief shes gotten is with an eastern approach.

Beamans husband, Troy, was diagnosed with stage four stomach cancer. He had trouble handling the side effects of radiation and chemotherapy treatments, but eastern medicine helped.

Troy was first diagnosed after serving in the Navy. While finishing his degree he wrestled on his college team, where he realized he was getting fatigued quickly.

Eventually doctors found a mass on Troys stomach. Later analysis revealed it was a rare cell type that has not had enough treatment trials, so it is unclear how it responds to chemotherapy, according to Troy.

To treat the pain and the side effects of the chemotherapy, I had acupuncture as well as other eastern medicine modalities, Troy said.

The mass has been removed, but Troy remains vigilant.

Patients looking to work with Kierstin Beaman can schedule a consultation to discuss their medical history and reason for coming in. Kierstin will use that to determine if she can help or should send them to someone who can, she said.

Treatments can vary based on what medications a patient is on, what theyve tried in the past and the severity of their symptoms. Those variables impact how often and what treatments they receive.

Each program is very specific to the person, Beaman said.

Generally patients can expect to see a cluster of treatments up front, intended to help the patient heal faster. Later on, patients likely will come in less often for maintaining their treatment.

Acupuncture needles stimulate nerves under the skin, which causes the release of neurotransmitters that regulate pain, according to Beaman.

When a needle goes into the body it stimulates a neural response, which treats the pain that is happening, Beaman said.

Along with acupuncture, Beaman practices herbology. Eventually she hopes to and integrative treatments such as ozone therapy, she said.

The clinic is at 3800 Coon Rapids Blvd. For more information go to mimaclinic.com.

Read more:

Stick it to pain: Acupuncturist opens in Coon Rapids - ECM Publishers

Data Bridge Market Reports Present Complementary and Alternative Medicine Market new report to its research database. The report first introduces the market basics like definitions, classifications, applications, and industry chain overview, and then industry policies and plans, product specifications, manufacturing processes, cost structures, and so on. The report highlights the change in the market which is taking place due to the moves of key players and brands such as product launches, joint ventures, mergers, and acquisitions that in turn change the view of the global face of the industry. According to the report, the global market is anticipated to witness a relatively higher growth rate during the forecast period. This Complementary and Alternative Medicine Market report also evaluates the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors, and Porters Five Forces Analysis.

This market research report surely provides productive ideas with which product can be made more effective and striking in the competitive market. The market data analyzed in this Complementary and Alternative Medicine Market report makes you achieve the business goal and objective in the predetermined time frame. This report deals with the precise study of the industry which explains the market definition, classifications, applications, engagements, and global industry trends. The Global Complementary and Alternative Medicine Market research report displays important product developments and tracks recent acquisitions, mergers, and research in the industry by the key players

Complementary and Alternative Medicine Market Insight:

Complementary and alternative medicine market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Rising prevalence cancer and other serious diseases worldwide and emerging markets are the factors responsible for the growth of this market.

Get Free Full PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) at:https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-complementary-and-alternative-medicine-market

This Free report sample includes:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

Prominent Key Players Covered in the report:

Nordic Naturals, Natures Bounty, Unity Woods Yoga Center, Columbia Nutritional, First Natural Brands Ltd., Ayush Ayurveda, Sheng Chang Pharmaceutical Company, Pure Encapsulations, LLC. Quantum-Touch, and Herb Pharm, LLC among others.

Key Pointers Covered in the Complementary and Alternative Medicine Market Industry Trends and Forecast

TheComplementary and Alternative Medicine marketreport provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Complementary and Alternative Medicine market.

Major Regions as Follows:

Get Table Of Contents of This Premium Research For Free @https://www.databridgemarketresearch.com/toc/?dbmr=global-complementary-and-alternative-medicine-market

The report includes accurately drawn facts and figures, along with graphical representations of vital market data. The research report sheds light on the emerging market segments and significant factors influencing the growth of the industry to help investors capitalize on the existing growth opportunities.

How insights and forecast from the reports could benefit you:

Why choose us:

Table Of Contents: Complementary and Alternative Medicine Market

Part 01:Executive Summary

Part 02:Scope of the Report

Part 03:Research Methodology

Part 04:Market Landscape

Part 05:Pipeline Analysis

Part 06:Market Sizing

Part 07:Five Forces Analysis

Part 08:Market Segmentation

Part 09:Customer Landscape

Part 10:Regional Landscape

Part 11:Decision Framework

Part 12:Drivers and Challenges

Part 13:Market Trends

Part 14:Vendor Landscape

Part 15:Vendor Analysis

Part 16:Appendix

Make an Inquiry of theComplementary and Alternative Medicine Market Report @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-complementary-and-alternative-medicine-market

To summarize:

The global Complementary and Alternative Medicine market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Customization of the Report:

We are grateful to you for reading our report. If you wish to find more details of the report or want customization, contact us. You can get a detail of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Contact:

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Continue reading here:

Complementary and Alternative Medicine Market Set to Register Healthy CAGR During 2027 - The Courier

While doing research as an undergraduate in Australia during the late-1970s, Naomi Rogers stumbled upon some dusty volumes of the British Medical Journal in her universitys medical library. They hadnt been used in a very long time, but for Rogers who was searching for debates, from the 1870s and 1880s, about whether women should be admitted to medical schools there was something magical in those pages. At the time torn between a career in music or history, she began to lean toward life as a historian.

Since joining the Yale faculty full time in 2001, Rogers has taught the history of medicine, specializing in disease and public health, gender and health, disability, feminist activism, and alternative medicine. Named a full professor in 2015, she has written about epidemic polio in two of her books, Dirt and Disease: Polio Before FDR and Polio Wars: Sister Kenny and the Golden Age of American Medicine, and is now working on a book that examines health activism since 1945.

During the COVID-19 pandemic, Rogers, professor in the history of medicine and history in the Faculty of Arts and Sciences, has been called upon by the media and others to offer a historical perspective on epidemics, public health, science, and medicine. She recently spoke with YaleNews about what past epidemics can teach us about the present crisis, what the pandemic has taught her as a historian, and how a rise in misinformation and anti-science sentiments during a public health emergency is nothing new.

The conversation has been edited and condensed.

You began your career as a historian of medicine just as the AIDS crisis was unfolding. Do you see any parallels between our experience of COVID-19 and AIDS?

I approach that question with humility, because I remember that many senior colleagues of mine in the 1980s were called upon by reporters to talk about AIDS. Then, we hadnt had much time to bring a more nuanced understanding of what a pandemic means in its particular time, and there were a lot of things we historians of medicine got wrong. While we understood some of the big issues around AIDS, such as discrimination and inadequate public health messaging, the constant hope all the way through the 1980s was that there would be a vaccine in just a couple of months. In many ways, when I look back on my dissertation, which sought to link the 1916 polio epidemic to our experience with AIDS, it was incredibly short-sighted, and much of it hasnt stood the test of time.

I do think this is a very different pandemic to be living through. AIDS was never seen as something that could harm everybody. It was seen as a targeted disease, even as a punishment for particular kinds of behavior by certain kinds of people, mostly gay people.

As a historian, it has been interesting to watch how we are dealing with a disease where its clear that anybody is a potential spreader and anybody is potentially vulnerable. It has profound implications for personal behavior changes. While AIDS also resulted in personal behavior changes, the disease was first really understood by the gay community, and also sex workers, as one that required behavior changes safer sex through the use of condoms.

Was community fear as widespread during the polio epidemic as it has been with COVID?

Polio was mainly viewed as a childrens disease, but that, of course, meant that every parent was concerned as well. It was a frightening community problem because nobody knew how it spread or who might be infected with the virus. Children who developed paralysis sometimes got better. But sometimes they didnt, and there was no way to predict that.

There were desperate efforts to come up with ways to protect the community. Even though public health professionals had been saying for years that polio is not spread by insects like mosquitoes, during the 1950s a lot of communities, including New Haven, paid for DDT spraying. It was a just-in-case kind of measure.

one of the things the public health establishment did extremely effectively was to make vaccinations part of a structural default system

Naomi Rogers

A particular challenge during the COVID pandemic is a disagreement about science itself, as weve seen with anti-science messaging, misinformation, or a lack of trust in scientific research. Is this something new?

No, its not. Its actually something Ive always been interested in, the sort of diverse, sometimes contradictory ways that people have sought to explain whats happening and, in some ways, disagree with the public health and science guidance.

Recently in the United States and in some other countries, public health officials have not been speaking with one voice. Im struck, for example, by how all the television networks have three or four medical consultants. Why do we have several on every network?

For many decades, especially after the 1918 flu epidemic, the public health establishment believed it had come up with really effective ways to educate people about the importance of public hygiene, personal hygiene, and, in the case of emerging vaccines, what was and was not a safe drug. But during the polio vaccine development in the 1950s, there was a reemergence of an anti-vaccine movement which wed seen in the 19th century. There was an argument that while polio might be spread by a virus, it wasnt why so many children were being paralyzed. Other explanations were given, the most popular being that parents were feeding their children too much sugar, salt, and soda, leading to poor nutrition. Poor nutrition was seen as the cause of the bodys vulnerability, and so the polio virus or any other virus, it was thought, was much more likely to make children very sick.

In the case of COVID-19, many people are hesitant about the vaccines because of how swiftly they were developed. How do public health officials convince people of a vaccines benefit?

What people mostly fear is that the vaccines were produced in a rushed period of time; they are afraid that scientists were influenced by outside forces to falsely say that this vaccine is safe or safe enough. But it should be pointed out that this vaccine was developed by research groups that have been working on coronaviruses for many years and have well-honed skills in DNA-type vaccine production. We are building on well-established methods, ones that are not new.

Does history teach us anything about how to sway anti-vaxxers?

People used to think that anti-vaxxers were ignorant, perhaps uneducated and out of touch, and that what they needed were helpful educational programs that would show them how wrong they are. We know now thats nave, and you dont talk to people who disagree with you by patronizing them. I dont know that we have quite figured out the best ways to reach anti-vax communities, because they are so diverse. You cant design a one-size-fits-all educational project and imagine that you are going to reach everyone.

In the last 20 years, one of the things the public health establishment did extremely effectively was to make vaccinations part of a structural default system, rather than asking people if it would be okay to vaccinate their children or themselves. For example, you cant send your children to public school if they havent been vaccinated. Because of this structural system, it was unusual for parents to refuse. In the future I would be amazed to hear if many schools would be willing to admit childrennotvaccinated against COVID.

there is now a wider recognition that thinking about science and medicine from a humanities point of view isa valuable resource.

Naomi Rogers

Has the pandemic raised new questions for you as a historian?

Ive had a number of questions about the logistics of the polio vaccine rollout in the 1950s and 1960s. I know almost nothing about the logistics, because historians have not been asked that question. Some historians are beginning research on the history of contact tracing, which we also dont really know very much about.

The pandemic has forced me in particular to be an adviser and mentor familiar with online primary and secondary materials, which the Yale undergraduates Im advising are using to write their senior essays. I now have to beef up my understanding of the kinds of sources available to them, how they search for them, and what they might be able to find or not find. Thats a whole kind of teaching Ive never done before.

Has COVID brought greater attention to the value of history of medicine and science as an academic field?

One of the things that has greatly heartened me is that there is now a wider recognition that thinking about science and medicine from a humanities point of view is not just a kind of luxury but a valuable resource. We are lucky here at Yale to have a vibrant group of scholars whove been exploring the history of medicine and science. We need humanities people to answer Where does our disgreement over the response to COVID come from? Did it exist before or was it invented by COVID? What is the relationship between disease and racial disparities? These are big questions that some of us have been addressing for many years.

See original here:

Society and disease: Lessons on pandemic from the pages of history - Yale News

A medication commonly used to treat deep vein thrombosis, Enoxaparin Sodium Injection, USP, has been voluntarily recalled due to a packaging error in which the labels dont accurately list the correct dose.

The recall, which was issued by pharmaceutical company Apotex Corp. Tuesday, Feb. 2, states that syringe barrels containing 150 mg/mL are mislabeled as containing 100mg/mL, and vice versa.

Enoxaparin sodium is an anticoagulant used to treat pulmonary embolism, blood clotting disorders, and deep vein thrombosis (DVT) a condition in which blood clots form in veins located deep within the body.

When administered with aspirin, it can help prevent angina (chest pain) and heart attacks.

Taking the incorrect dose of the injection can lead to bleeding and clotting complications.

Incorrect syringe barrel marking could lead to miscalculation and inaccurate dose administration to patients, the recall states.

The affected products were produced in two batches: CS008 and CT003.

The batches were distributed by Apotex Corp. nationwide to wholesalers and warehousing chains.

If a patient prescribed a 150 mg/mL bottle received a mislabeled bottle that contained 100 mg/mL, they could receive 2 mg of enoxaparin rather than 2.5 mg of enoxaparin, the recall explains.

If a patient who typically uses a 100 mg/mL bottle received a mislabeled bottle that contained 150 mg/mL, they might end up taking 3.75 mg of enoxaparin instead of 3 mg of enoxaparin.

The prescribed dosing of enoxaparin sodium is based off of a persons age, weight, condition being treated, severity of the condition, overall health, and how well they tolerate the medication.

The injection is administered either once or twice a day.

Taking a higher dose of enoxaparin sodium can lead to bleeding complications.

Some patients could experience symptoms like bruises on mucosal or skin surfaces, blood in urine or stool, said Dr. Natalia Neparidze, a Yale Medicine hematologist and assistant professor of medicine at Yale School of Medicine.

Too low of a dose can lead to clotting.

Taking too little of the intended dose of the drug will result in suboptimal, inadequate anticoagulation, putting patients at risk for recurrent or worsening thrombosis, such as deep venous thrombosis or pulmonary embolism, Neparidze said.

Taking a lower dose may cause pain or swelling in the extremities in patients with deep vein thrombosis.

Dr. Britt Tonnessen, a Yale Medicine vascular and endovascular surgeon and associate professor of surgery at Yale School of Medicine, said the warning signs of a clot include shortness of breath or pain with breathing, racing heart, or stroke.

Its unlikely that someone could detect their dose is off, Tonnessen added.

According to Neparidze, very minor dosing differences may not cause significant bleeding or clotting complications. But if the incorrect dose is continually taken, complications may occur.

Because the dose is based on weight, people who are under or overweight may be more sensitive to changes in dosing.

While injecting a reduced dose on a single or a few occasions is unlikely to cause harm, continued use of a lower dose than prescribed could lead to a recurrence of blood clots, Tonnessen said.

Anyone with a syringe barrel from the affected batches should immediately talk with a doctor and have the medication replaced with the correct dose, Neparidze said.

Doctors dont recommend skipping a dose.

In the event that there will be a delay in receiving the new batch of medication, patients should contact their doctor to make arrangements for alternative treatment in the interim, Tonnessen said.

Anyone who received the affected medication should contact Inmar Rx Solutions at 1-855-667-8717 to arrange a return, the recall states.

Any adverse events should be reported to the FDAs MedWatch Adverse Event Reporting program.

A medication commonly used to treat deep vein thrombosis, Enoxaparin Sodium Injection, USP, has been voluntarily recalled due to a packaging error in which the labels dont accurately list the correct dose.

Taking the incorrect dose of the injection can lead to bleeding and clotting complications.

Doctors dont recommend skipping a dose, so if you have a bottle included in the recall, talk with your doctor immediately.

See original here:

DVT Medication Recalled, Here's What to Know Now - Healthline

Theres a whole lot going on in Foo Fighters world this week. After months of waiting, the band finally debuted their 10th studio album Medicine At Midnight on Friday, Feb. 5.

Now, Dave Grohl is reflecting back on his career and has revealed why hes not concerned about what Kurt Cobain wouldve thought of Foo Fighters. As well, Grohl has also opened up about musical prodigy Nandi Bushell and their recent drum battle. To top it all off, Foo Fighters have even debuted a new cover of a Tom Petty classic.

Following the death of his Nirvana bandmate Kurt Cobain in 1994, Dave Grohl went on to create Foo Fighters. During the early stages of Foo Fighters, Grohl and his new bandmates were often compared to Nirvana, something that always bothered Grohl. Now, 25 years after Foo Fighters start, Grohl is opening up more about Kurt Cobain.

During a recent tell-all interview with NME, Grohl shares that hes not concerned about what Kurt Cobain wouldve thought of his career in the Foo Fighters. Why? Well, Grohl has already spent over two decades having his work critiqued by onlookers.

No, I dont and Ill tell you why, he says. For 25 fucking years, thats been something Ive been judged by and from the get-go, you have to realize that its a dangerous place to be. You cant create or judge anything by someone elses standards.

Elsewhere in the interview, Grohl also recalls the fear he felt when he began working on Foo Fighters first album just 6 months after Cobain died.

Its funny because I kept this little project a secret for so long before it became a band, he says. And one of the reasons was for fear that people would judge it. Thats all of the weird little demo tapes Id done, I just didnt feel comfortable sharing because they were mine. There was some safety and security in just keeping them to myself, so one of the reasons I started this band was to move on from the past. The band truly represents this continuation of life because I didnt want to remain in that place forever and I just couldnt. I would have suffocated.

Now, 25 years later, Foo Fighters have dropped their 10th studio album Medicine At Midnight. As it turns out, Grohls recent drum battle with musical prodigy Nandi Bushell inspired him to put out this new album.

The thing that inspired me the most to release this album was that drum battle I had with Nandi, Grohl tells Kerrang!. More than just some back and forth between two musicians, this battle of technical proficiency, it was spreading joy and happiness. People would turn on their computer or phone and for three and a half minutes they would smile because a 10-year-old girl was kicking my fucking ass in adrum battle. To me, thats what the worldneeded.

To help celebrate the release of Medicine At Midnight, Foo Fighters recently performed a few songs for SiriusXM. Along with their new track Cloudspotter and classic Best Of You, Foo Fighters also took on Tom Pettys Honey Bee.

Medicine At Midnight is available to stream below.

What are your reactions to Dave Grohls comments about Kurt Cobain? What is your favorite song off of Medicine At Midnight? Let us know in the comments below.

See the article here:

Dave Grohl on Kurt Cobain's opinion of Foo Fighters l Alternative Press - Alternative Press

Here are the biggest court stories that have featured in the SNJ, Gazette Series or Wilts Glos Standard over the past few days.

An Olveston man has been jailed for his part in a plot to smuggle cocaine worth 500k into the UK.

Bertram Jack Fallon, 31, and Arron James Collins, 35, used encrypted messaging services to arrange the importation of five kilograms of cocaine - which Border Force officers seized at London Gateway Parcel Hub in January last year.

At Bristol Crown Court on Tuesday, Fallon, of Bramley Close, was jailed for six years and six months.

FULL STORY: Olveston man jailed for smuggling cocaine worth 500k in protein powder

A Cam man who has been convicted for the second time of downloading indecent images of children will spend the next 10 months behind bars.

Matthew Gardner, 31, of Manor Avenue, pleaded guilty to downloading indecent images in all three categories of seriousness - A, B and C - and breaching the terms of a sexual harm prevention order.

FULL STORY: Cam man jailed for downloading indecent images of children

A Stroud man has been convicted him of two offences of sexually assault.

The victim told a jury that she had obtained restraining orders to keep Jonathan Nash, of Allen Road, Paganhill, away from her but he continued to plague her life over a period of more than a year.

Nash was unanimously found guilty and was remanded in custody to await sentence next month.

FULL STORY: Stroud man plagued life of woman and sexually assaulted her twice

A bookkeeper defrauded an alternative medicine a company in Stroud out of 67,000

Edward Humphrey, 42, of Overbrook Road, Hardwicke, pleaded guilty to dishonestly abusing his position at In-Light Ltd, which provides alternative medicine courses, by making unauthorised bank transfers to Stroud Accounting Solutions Ltd.

He will be sentenced next month.

FULL STORY: Bookkeeper stole nearly 70k from homeopathy business in Stroud

A Royal Wootton Bassett man is said to have suffocated his girlfriend using a plastic bag in an alleged murder bid.

Appearing before Swindon Magistrates Court on Wednesday morning, Nicholas Bray, 23, of no fixed address, entered no pleas to an allegation of attempted murder.

He has also been charged with sending a social media message to a Wiltshire Police officer last November threatening to shoot and decapitate him.

District Judge Joanna Dickens remanded him into custody to appear before Bristol Crown Court for a pre-trial preparation hearing on February 15.

FULL STORY: Man, 23, in court charged with attempted murder of girlfriend

See the original post:

IN THE DOCK: The biggest Gloucestershire court stories this week - South Cotswolds Gazette

A bookkeeper defrauded analternative medicinea company in Stroud out of nearly 70k, a court heard

Edward Humphrey, 42, of Overbrook Road, Hardwicke, pleaded guilty to dishonestly abusing his position at In-Light Ltd, which provides alternative medicine courses, by making unauthorised bank transfers to Stroud Accounting Solutions Ltd.

The fraud amounted of 67,000, a court heard on Thursday.

In-Light Limited is the holding company for the School of Homeopathy, The School of Health and Yondercott Press and is listed at an address inRodborough Hill,Stroud.

It offers alternative medicine courses, seminars, books and webinars focusing on nutrition, homeopathy, herbal medicine, yoga, Indian and Chinese Medicine.

Stroud Accounting Solutions Ltd, of which Humphrey was the only director, was dissolved in November last year, according to Companies House.

He admitted to intending to make the gain by fraud between January 1, 2018 and July 31, 2019.

The charge, which he admitted at Cheltenham Magistrates Court, also said he cancelled a direct debit payable to HMRC without authority and made bank transfers for VAT to another account.

Humphrey was released on unconditional bail and will be sentencedat Gloucester Crown Court on March 5.

Link:

Bookkeeper stole from School of Homeopathy, Stroud - Stroud News and Journal

Health News of Wednesday, 3 February 2021

Source: 3 News

Founder of the African University College of Communications (AUCC), Kojo Yankah

Founder of the African University College of Communications (AUCC), Kojo Yankah, has called on African leaders to rise and attempt to develop herbal medicines to tackle the coronavirus and stop the over-reliance on the West for vaccines.

He said he is still waiting for the day authorities will announce that the first herbal medicine for clinical trials for the treatment of Covid-19, has been approved in Africa.

In a Facebook post, he said African Media: I am still waiting for Ghanaian/African media HEADLINE BREAKING NEWS that Ghanas FDA has approved the first herbal medicine for Clinical Trials for the TREATMENT of COVID-19?.

Rather I am reading headlines suggesting Vaccines are on the way! Oh, Africa, when can we BELIEVE in ourselves! Wake Up Africa! 80% of our people have survived thousands of years on Traditional Herbal Medicine, which we shamefully call alternative medicine.

His comments come after the Food and Drugs Authority (FDA) on Monday, February 1, announced in a statement that it has approved the first herbal medicine for a clinical trial on the coronavirus treatment in the country.

The statement said the School of Public Health at the Kwame Nkrumah University of Science and Technology, (KNUST), submitted a clinical trial application in September 2020.

The Food and Drugs Authority (FDA), The National Medicine Regulatory Agency (NMRA) in Ghana, has approved a herbal medicine, Cryptolepis sanguinolenta, locally known as Nibima for clinical trials in January 2021.

It added In the search for a treatment for the ongoing COVID-19 pandemic, researchers from the School of Public Health at the Kwame Nkrumah University of Science and Technology, (KNUST), submitted a clinical trial application in September 2020 to assess the safety and efficacy of Cryptolepis sanguinolenta as a potential treatment for COVID-19. This follows results from laboratory studies conducted by the KNUST research team which points in the direction of possible clinical benefits.

Meanwhile, President Nana Addo Addo Dankwa Akufo-Addo has announced that vaccines for the coronavirus will arrive in the country by March this year.

Read the original post:

Coronavirus: I look forward to the approval of herbal medicines for treatment Yankah - GhanaWeb

The North Central Regional Health Authority (NCRHA) has denied newspaper reports that a patient didnt receive care due to the Ministry of Health not supplying the required drugs.

In a statement, the NCRHA said Seema Abdool-Gobin, who was reportedly diagnosed with lymphoma last year, refused to undergo treatment despite pleas from doctors on several occasions.

The NCRHA said she refused, telling doctors she would seek herbal treatment instead.

The Authority provided a timeline on its attempts at medical intervention.

In May 2020, in the early onset after her diagnosis, Seema refused treatment, indicating to our specialist clinicians and physicians that she had decided to go herbal and pursue alternative medicine instead of our specialist teams medically prescribed advice.

NCRHA contacted the patient and pleaded again in September 2020, but to no avail, as she refused again.

Given the Authoritys interest in ensuring the well-being of our patients, and in sincere attempt to ensure that necessary clinical intervention was provided to prevent worsening of her condition, and the NCRHA brought in the entire family for consultation with a team of physicians in October 2020.

The NCRHA said it again begged for her to come in for treatment but her husband said at the time that they had done their own research and did not trust chemotherapy.

Prior to her return visit to the EWMSC in October, the NCRHA said medical records show that Seema visited the Couva Health Centre (SWRHA), where she was advised to go to the San Fernando General Hospital, but she insisted that she would go to EWMSC.

In fact, the Carapichaima resident, signed against clinical advice and counsel from SWRHA medical team to pursue treatment at the San Fernando General Hospital, indicating that she (preferred) to have treatment at Eric Williams Medical Sciences Complex, where she consistently refused treatment, the NRCHA noted.

It said fluid in her lungs was drained on October 18, while she was admitted.

She was also recommended for pleurodesis - a more specialised treatment utilising advanced medication to prevent increased build up fluid in the lungs thereafter.

But, she refused and subsequently during her in-patient stay, she changed her mind.

The deliberation did result in some delay, and put the intervention at a disadvantage, but we were eventually able to do the procedure, the NCRHA.

The Authority said these delays on the patients part made it increasingly difficult to sufficiently project and plan for specialised pharmaceuticals interventions that have to be ordered, as she refused treatment at practically every step of the way.

The NCRHA noted that she finally agreed to treatment at the end of October and had clinic appointments the following month.

Following a visit to the Thoracic Surgical Unit (TSU) on November 10, 2020 she confirmed that she was willing to take the medication after which the drugs were ordered, and are available.

See the original post:

NCRHA denies newspaper report, says patient refused treatment - Loop News Trinidad and Tobago

Support for cancer research could see boosts in the new presidential administration.

As the National Cancer Act turns 50 years old this year, federal leaders are highlighting how cancer care progressed through the years and discussed the technology innovation that'sstill to come. Leaders at the National Cancer Institute welcomed First Lady Jill Biden in a virtual meeting with agency researchers Wednesday to highlight progress incancer care access, clinical trial developmentsand even support for the COVID-19 pandemic.

"The president and I stand with you, Biden said, in her remarks about how cancer has impacted her own life.

The first time I heard the diagnosis for someone I loved was in my early 40s, and the year it happened, not one but actually four of my friends found out that they had breast cancer, Biden said. Cancer took the life of both my parents. My sister had to have an auto-stem cell transplant. And then there was our son, Beau, as you refer to. Cancer touches us all.

Cancer care innovation has been a presidential priority before under the Obama administration, when President Joe Biden was vice president. In 2016, NCI launched the Cancer Moonshot initiative to accelerate cancer research progress. The initiative received funding over seven years with the passing of the 21st Center Cures Act that year.

The first lady praised NCI for its efforts toward cancer research in generalas well as those doneunderthe Moonshot initiative.

Youve brought the Cancer Moonshot to where it is today, Biden said. Youve dedicated years to studying our immune systems and supporting clinical trials. Youve lifted up community-based clinics and treatment research. Youve led breakthroughs and discovered new ways to test, and though this last year has been so difficult, NCI has risen to meet the challenge, uncovering how this pandemic has affected rates and figuring out how to continue this work your work.

NCI Director Dr. Ned Sharpless introduced three leading NCI researchers who highlighted how decades of work and fundinghave led to cutting-edge advancements in cancer research and treatment.

For one, NCI Community Oncology Research Program Director Dr. Worta McCaskill-Stevens, highlighted advancements the agencyhas made in broadening clinical trials by improving access and seeking ways to increase participation in these trials.

Weve learned a lot from the community sites, McCaskill-Stevens said of her program's 46 community sites. This has led us to great insights about the importance, for example, of understanding chronic diseases, diabetes and hypertension, which is so prevalent in underserved communities.

The program has also engaged in individualized or precision trials through efforts like theTrial Assigning Individual Options for Treatment (TAILORx) trial. McCaskill-Stevens said NCI enrolled over 10,000women into this precision cancer trial and found that only about 20% of women with early-stage breast cancer benefit from chemotherapy after surgery.

These data affect and apply to 50% of breast cancer in the United States, McCaskill-Stevens added. We now know using a molecular test that we can identify those women who only need entire endocrine therapy to reduce the risk of recurrence. These women now dont have to have chemotherapy side effects, such as nausea, fatigue, risk of infection or hair loss.

Another leader, NCI Research Staff Clinician Dr. Stephanie Goff,discussed cellular immunotherapy, or the attempt to get the bodys immune cells to identify and attack cancer cells.

If we can find those [antibody] cells, what can we learn from them, and how can we give them back to patients? Goff said. If we can harness that, then we can just set the bodies on top of itself to the Achilles heel of that cancer, that it has changed and made itself visible.

Cellular immunotherapy has only emerged in recent years as a potentially viable alternative treatment for cancer.With the many families who are suffering from the disease, Goff is thankful that NCI gives her team the resources to continue pioneering new solutions and treatment options for patients.

The final official, NCI Director of the Vaccine, Immunity and Cancer Program Dr. Ligia Pinto,led work atthe Frederick National Laboratory for Cancer Research in serology, which measures antibodies in the blood and predicts response to infection or vaccination. This programhad a huge impact in the national COVID-19 response.

COVID-19 serology tests [have been] our public health tools for identifying individuals who were previously infected with SARS CoV-2 or were vaccinated and therefore may be protected against the new infection, Pinto said. My laboratory at the Frederick National Lab has leveraged our expertise in studying immune responses to human papilloma virus infection and cervical cancer vaccines to develop serology tests and standards that are relevant to understand SARS CoV-2 to infection and immune responses to the virus.

At the beginning of the pandemic as the nation was learning about and seeking serology tests for COVID-19, the Food and Drug Administration asked Pintos labto assist in the evaluation of commercially available antibody tests for COVID-19, which she said lead to the evaluation of more than 100 tests and eventual approval of tests used today.

Recently, NCI launched an initiative called the Serology Sciences Network, Pinto added. It isone of the largest coordinated efforts across 25 of the countrys top biomedical research institutions to collaboratively study immune responses to COVID-19.

We believe that this collaborative network is an outstanding resource for tackling the emerging challenges associated with new viral variants and understanding their potential impact on antibody testing and vaccine efficacy, Pinto added.

The first lady called the National Institutes of Health the national institutes of hope, meaning the collaboration and commitment that NCI and other NIH institutesgive to medicine and science give her and other Americans hope.

So many people in this country are patients that have cancer or have someone they love thats dealing with cancer, Biden said. One thing that we found when in the Obama administration was the benefit of collaboration and how much that meant, whether it was through all the agencies of the government just working together."

Read more here:

Cancer Innovation Highlighted During First Lady's Visit to NCI - GovernmentCIO Media